Establishment of a mouse xenograft model for mycosis fungoides

被引:26
作者
Thaler, S
Burger, AM
Schulz, T
Brill, B
Bittner, A
Oberholzer, PA
Dummer, R
Schnierle, BS
机构
[1] Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Germany
[2] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Spital Zurich, Dermatol Klin, Zurich, Switzerland
关键词
animal model; cutaneous T-cell lymphoma; mycosis fungoides; xenograft;
D O I
10.1111/j.0906-6705.2004.00201.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mycosis fungoides (MF) is the most frequent variant of cutaneous T-cell lymphomas (CTCLs). MF primarily involves the skin initially with patches and plaques. In later stages, cutaneous tumors develop and tumor cells may spread to lymph nodes and finally to visceral sites. Here, we describe an animal model for MF in immune-deficient nude mice, using the CTCL cell line MyLa. Subcutaneous transplantation of MyLa cells leads to the formation of cutaneous tumors in 80% of the mice (50/60 total). Spread of tumor cells to visceral sites was detected by immunohistochemistry and polymerase chain reaction (PCR)-based detection of specific T-cell receptor-gamma rearrangement. MyLa cells were found circulating in the blood, lymph nodes, and in blood vessels of heart, kidney, lung, and liver. In lung and liver tissue, tumor cells presented perivascular invasion, but no large secondary tumors developed. The nude mouse model described here will be a valuable test system for new therapeutic approaches for the treatment of MF and opens the unique opportunity to study the disease in vivo.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 16 条
[1]  
AUSUBEL FM, 1988, CURRENT PROTOCOLS IM
[2]   RAPID, NONRADIOACTIVE DETECTION OF CLONAL T-CELL RECEPTOR GENE REARRANGEMENTS IN LYMPHOID NEOPLASMS [J].
BOURGUIN, A ;
TUNG, R ;
GALILI, N ;
SKLAR, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) :8536-8540
[3]   PROSPECTIVE STAGING EVALUATION OF PATIENTS WITH CUTANEOUS T-CELL LYMPHOMAS - DEMONSTRATION OF A HIGH-FREQUENCY OF EXTRA-CUTANEOUS DISSEMINATION [J].
BUNN, PA ;
HUBERMAN, MS ;
WHANGPENG, J ;
SCHECHTER, GP ;
GUCCION, JG ;
MATTHEWS, MJ ;
GAZDAR, AF ;
DUNNICK, NR ;
FISCHMANN, AB ;
IHDE, DC ;
COHEN, MH ;
FOSSIECK, B ;
MINNA, JD .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (02) :223-230
[4]   PATHOLOGY OF CUTANEOUS T-CELL LYMPHOMA [J].
BURG, G ;
DRUMMER, R ;
DOMMANN, S ;
NESTLE, F ;
NICKOLOFF, B .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (05) :961-&
[5]   ESTABLISHMENT OF A HUMAN CUTANEOUS T-CELL LYMPHOMA IN C.B-17 SCID MICE [J].
CHARLEY, MR ;
THARP, M ;
LOCKER, J ;
DENG, JS ;
GOSLEN, JB ;
MAURO, T ;
MCCOY, P ;
ABELL, E ;
JEGASOTHY, B .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (03) :381-384
[6]  
Coligan JE, 1999, CURRENT PROTOCOLS IM
[7]   Mycosis fungoides and Sezary syndrome [J].
Diamandidou, E ;
Cohen, PR ;
Kurzrock, R .
BLOOD, 1996, 88 (07) :2385-2409
[8]   Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells [J].
Döbbeling, U ;
Dummer, R ;
Laine, E ;
Potoczna, N ;
Gin, JZ ;
Burg, G .
BLOOD, 1998, 92 (01) :252-258
[9]   Pathogenesis of cutaneous lymphomas [J].
Dummer, R ;
Willers, J ;
Kamarashev, J ;
Urosevic, M ;
Döbbeling, U ;
Burg, G .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2000, 19 (02) :78-86
[10]   MYCOSIS-FUNGOIDES - SURVIVAL, PROGNOSTIC FEATURES, RESPONSE TO THERAPY, AND AUTOPSY FINDINGS [J].
EPSTEIN, EH ;
LEVIN, DL ;
LUTZNER, MA ;
CROFT, JD .
MEDICINE, 1972, 51 (01) :61-+